Comparable stake leader
Ayrton Capital LLC
SEC ownership of Bionano Genomics, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001411690.
Disclosed value leader
Soheil Shams
Comparable rows
39/50
Latest evidence
21 Aug 2026
- Public ticker
- BNGO on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Ayrton Capital LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
39 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Ayrton Capital LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
21 Aug 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001411690
- Issuer location
- San Diego, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Bionano Genomics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ayrton Capital LLC
Disclosed value leader
Soheil Shams
Comparable rows
39/50
Latest evidence
21 Aug 2026
13D/G
13F
3/4/5
Lead comparable stake: 10%
11 rows are not safely comparable across share classes.
13D/G row: Ayrton Capital LLC
Showing 1-8 of 50 holder rows.
Quick read
Ayrton Capital LLC leads the comparable SEC ownership view at 10%.
39 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ayrton Capital LLC's linked filing trail.
Comparable ownership
Top 5
Ayrton Capital LLC
10%
CVI Investments, Inc.
9.9%
Lind Global Fund III LP
9.4%
Lincoln Alternative Strategies LLC
5.4%
INTRACOASTAL CAPITAL, LLC
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ayrton Capital LLC |
13D/G
|
10%
|
$903,140
528,245 shares
|
$0 | 30 Sep 2025 |
| CVI Investments, Inc. |
13D/G
|
9.9%
|
$1,568,562
1,307,135 shares
|
+$213,269 | 30 Jun 2026 |
| Lind Global Fund III LP |
13D/G
|
9.4%
|
$1,669,500
1,050,000 shares
|
+$851,703 | 31 Dec 2025 |
| Lincoln Alternative Strategies LLC |
13D/G
|
5.4%
|
$2,021,250
525,000 shares
|
$0 | 17 Sep 2025 |
| INTRACOASTAL CAPITAL, LLC |
13D/G
Mitchell P. Kopin
|
5%
|
$1,957,398
508,415 shares
|
$0 | 16 Sep 2025 |
| Iroquois Capital Management, LLC |
13D/G
Richard Abbe
|
5%
|
$1,088,384
98,944 shares
|
$0 | 30 Sep 2025 |
| Cable Car Capital, LP |
13F
Company
|
3%
|
$702,500
216,821 shares
|
— | 30 Jun 2026 |
| GSA CAPITAL PARTNERS LLP |
13F
Company
|
1.1%
|
$170,000
150,284 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$4,860.
Buys
$4,860
Insiders: 1
Sells
$0
Insiders: 0
Net
+$4,860
Shares: +4,000
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 4,000
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 4,000 | 0 | $4,860 | $0 | +$4,860 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-19 of 19 reporting-owner rows connected to Bionano Genomics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
19
Largest Forms 3/4/5 holder
Soheil Shams
Net 12M change
+$4,860
Latest report
21 Aug 2026
Recent insider transactions for Bionano Genomics, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Albert Luderer | BNGO | Common Stock | Purchase | $4,860 | $1.22 | 4,000 | 4,000 | 21 Aug 2026 | Traditional IRA | |
| Mark Adamchak | BNGO | Stock Option (Right to Buy) | Award | 5,000 | 5,000 | 03 Aug 2026 | Direct | |||
| Jonathan Dixon V | BNGO | Stock Option (Right to Buy) | Award | 15,000 | 15,000 | 03 Aug 2026 | Direct | |||
| Mark Oldakowski | BNGO | Stock Option (Right to Buy) | Award | 15,000 | 15,000 | 03 Aug 2026 | Direct | |||
| Alex Reid Hastie | BNGO | Stock Option (Right to Buy) | Award | 54,000 | 54,000 | 03 Aug 2026 | Direct | |||
| Jonathan Dixon V | BNGO | Common Stock | Tax liability | -9.13% | -24 | 239 | 03 Jun 2026 | Direct | ||
| Mark Oldakowski | BNGO | Common Stock | Tax liability | -3.02% | -27 | 868 | 03 Jun 2026 | Direct | ||
| Alka Chaubey | BNGO | Common Stock | Tax liability | -3.73% | -24 | 620 | 03 Jun 2026 | Direct | ||
| Mark Adamchak | BNGO | Common Stock | Tax liability | -2.69% | -7 | 253 | 03 Jun 2026 | Direct | ||
| Aleksandar Rajkovic | BNGO | Stock Option (Right to Buy) | Award | 9,149 | 9,149 | 14 May 2026 | Direct | |||
| Yvonne Linney | BNGO | Stock Option (Right to Buy) | Award | 9,149 | 9,149 | 14 May 2026 | Direct | |||
| Kristiina Vuori MD | BNGO | Stock Option (Right to Buy) | Award | 9,149 | 9,149 | 14 May 2026 | Direct | |||
| Christopher J. Twomey | BNGO | Stock Option (Right to Buy) | Award | 9,149 | 9,149 | 14 May 2026 | Direct | |||
| David L. Barker | BNGO | Stock Option (Right to Buy) | Award | 9,149 | 9,149 | 14 May 2026 | Direct | |||
| Alka Chaubey | BNGO | Common Stock | Tax liability | -2.72% | -18 | 644 | 17 Feb 2026 | Direct | ||
| Mark Adamchak | BNGO | Common Stock | Tax liability | -1.14% | -3 | 260 | 17 Feb 2026 | Direct | ||
| Jonathan Dixon V | BNGO | Common Stock | Tax liability | -2.23% | -6 | 263 | 17 Feb 2026 | Direct | ||
| Mark Oldakowski | BNGO | Common Stock | Tax liability | -2.19% | -20 | 895 | 17 Feb 2026 | Direct | ||
| R. Erik Holmlin | BNGO | Common Stock | Tax liability | -2.99% | -51 | 1,657 | 17 Feb 2026 | Direct | ||
| Mark Adamchak | BNGO | Stock Option (Right to Buy) | Award | 10,890 | 10,890 | 02 Feb 2026 | Direct | |||
| Jonathan Dixon V | BNGO | Stock Option (Right to Buy) | Award | 26,117 | 26,117 | 02 Feb 2026 | Direct | |||
| Alka Chaubey | BNGO | Stock Option (Right to Buy) | Award | 27,737 | 27,737 | 02 Feb 2026 | Direct | |||
| Mark Oldakowski | BNGO | Stock Option (Right to Buy) | Award | 27,737 | 27,737 | 02 Feb 2026 | Direct | |||
| R. Erik Holmlin | BNGO | Stock Option (Right to Buy) | Award | 69,484 | 69,484 | 02 Feb 2026 | Direct | |||
| Mark Oldakowski | BNGO | Common Stock | Tax liability | -6.06% | -59 | 915 | 11 Sep 2025 | Direct | ||
| Alka Chaubey | BNGO | Common Stock | Tax liability | -7.15% | -51 | 662 | 11 Sep 2025 | Direct |
* marks a reported price that did not pass the local price check.